2022 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸ : 2022-06-10±³À°ÀÏÀÚ : 2022-06-10
±³À°Àå¼Ò : ´ëÀü DCC 2Ãþ ±×·£µåº¼·ë
±³À°ÁÖÁ¦ :
2022 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540
À̸ÞÀÏ :
kalc@lungca.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, °áÇÙ°ú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
´ëÀü±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í »çÀüµî·Ï ȸ¿ø: 50,000¿ø/ ºñȸ¿ø 70,000¿ø ÇöÀåµî·Ï ȸ¿ø: 60,000¿ø/ ºñȸ¿ø 80,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 12:10~12:50 Realize More TOMORROWs Together for mNSCLC patients with Pembrolizumab in the 1st line Howard Jack West(City of Hope Comprehensive Cancer Center)
ÈÞ½Ä 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 12:50~13:10 Coffee break ()
±³À°½Ã°£ 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 13:10~13:40 Immune microenvironment & organotropism À̽ÂÇö(°æÈñÀÇ´ë)
±³À°½Ã°£ 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 13:40~14:10 Brain tropism ¹ÚÁöÀº(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 14:10~14:40 Bone tropism ÀÌÁÖÈ£(¼¿ïÀÇ´ë)
ÈÞ½Ä 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 14:40~15:00 Coffee break ()
±³À°½Ã°£ 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 15:00~15:20 Update in staging and WHO classification ¼º¿¬Àº(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 15:20~15:40 Progress in surgical approach À̱ٵ¿(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 15:40~16:00 Role of Radiotherapy ³ëÀç¸í(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 16:00~16:20 Evolution in chemotherapy ÀÌÀ±±Ô(¼º±Õ°üÀÇ´ë)
ÈÞ½Ä 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 16:20~16:40 Coffee break ()
Åä·Ð 06-10 ´ëÀüDCC 2Ãþ ±×·£µåº¼·ë 16:40~17:30 Mx of stage Ib NSCLCa ÀüÀçÇö(¼¿ïÀÇ´ë)